An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases

Progress in Cardiovascular Diseases

Volumn 61, Issue 2, 2018, Pages 142-150

  Elagizi, Andrew ^a   Kachur, Sergey ^a   Lavie, Carl J ^a   Carbone, Salvatore ^b   Pandey, Ambarish ^c   Ortega, Francisco B ^d   Milani, Richard V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Atrial fibrillation; Cardiorespiratory fitness; Cardiovascular; Cardiovascular disease; Coronary heart disease; Heart failure; Obesity; Obesity paradox; Physical activity

Indexed keywords

GLUCOSE;

ADIPOCYTE; ATRIAL FIBRILLATION; BODY FAT; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FASTING; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MACROPHAGE; METABOLIC DERANGEMENT; METABOLIC DISORDER; METABOLICALLY HEALTH OBESITY; METABOLISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PREVALENCE; PROGNOSIS; REVASCULARIZATION; REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ENERGY METABOLISM; EXERCISE; HEALTH STATUS; HEALTHY LIFESTYLE; METABOLICALLY BENIGN OBESITY; PROTECTION; RISK FACTOR;

ADIPOSITY; BODY MASS INDEX; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; EXERCISE; HEALTH STATUS; HEALTHY LIFESTYLE; HUMANS; OBESITY; OBESITY, METABOLICALLY BENIGN; PROGNOSIS; PROTECTIVE FACTORS; RISK FACTORS;

EID: 85050987621     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2018.07.003     Document Type: Review

References (111)

1. NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 390:10113 (2017), 2627–2642, 10.1016/S0140-6736(17)32129-3.
2. Lavie, C., Arena, R., Alpert, M., Milani, R., Ventura, H., Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol 15:1 (2018), 45–56, 10.1038/nrcardio.2017.108.
3. Lavie, C.J., De Schutter, A., Parto, P., et al. Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated. Prog Cardiovasc Dis 58:5 (2016), 537–547, 10.1016/j.pcad.2016.01.008.
4. Lavie, C.J., Sharma, A., Alpert, M.A., et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58:4 (2016), 393–400, 10.1016/j.pcad.2015.12.003.
5. Lavie, C.J., Obesity and prognosis-just one of many cardiovascular paradoxes?. Prog Cardiovasc Dis 56:4 (2014), 367–368, 10.1016/j.pcad.2013.10.017.
6. Park, J., Ahmadi, S.-F., Streja, E., et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 56:4 (2014), 415–425, 10.1016/j.pcad.2013.10.005.
7. Lavie, C.J., De Schutter, A., Milani, R.V., Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol 11:1 (2015), 55–62, 10.1038/nrendo.2014.165.
8. Kachur, S., Lavie, C.J., De Schutter, A., Milani, R.V., Ventura, H.O., Obesity and cardiovascular diseases. Minerva Med 108:3 (2017), 212–228, 10.23736/S0026-4806.17.05022-4.
9. WHO, Obesity fact sheet (no.311). http://www.wpro.who.int/mediacentre/factsheets/obesity/en/ [Published 2014. Accessed May 17, 2018].
10. Dickey, R.A., Bray, G.A., AACE/ACE position statement on the prevention, diagnosis, and treatment of obesity. Endocr Pract 4:5 (1998), 297–350.
11. Romero-Corral, A., Somers, V.K., Sierra-Johnson, J., et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 32:6 (2008), 959–966, 10.1038/ijo.2008.11.
12. Gallagher, D., Heymsfield, S.B., Heo, M., Jebb, S.A., Murgatroyd, P.R., Sakamoto, Y., Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:3 (2000), 694–701, 10.1093/ajcn/72.3.694.
13. Carbone, S., Lavie, C.J., Arena, R., Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc 92:2 (2017), 266–279, 10.1016/j.mayocp.2016.11.001.
14. Lavie, C.J., McAuley, P.A., Church, T.S., Milani, R.V., Blair, S.N., Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 63:14 (2014), 1345–1354, 10.1016/j.jacc.2014.01.022.
15. Oliveros, E., Somers, V.K., Sochor, O., Goel, K., Lopez-Jimenez, F., The concept of normal weight obesity. Prog Cardiovasc Dis 56:4 (2014), 426–433, 10.1016/j.pcad.2013.10.003.
16. See, R., Abdullah, S.M., McGuire, D.K., et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis. The dallas heart study. J Am Coll Cardiol 50:8 (2007), 752–759, 10.1016/j.jacc.2007.04.066.
17. Ortega, F.B., Sui, X., Lavie, C.J., Blair, S.N., Body mass index, the most widely used but also widely criticized index Would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality?. Mayo Clin Proc 91:4 (2016), 443–455, 10.1016/j.mayocp.2016.01.008.
18. Iliodromiti, S., Celis-Morales, C.A., Lyall, D.M., et al. The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. Eur Heart J 39:17 (2018), 1514–1520, 10.1093/eurheartj/ehy057.
19. Khan, S.S., Ning, H., Wilkins, J.T., et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol 3:4 (2018), 280–287, 10.1001/jamacardio.2018.0022.
20. Padwal, R., McAlister, F.A., McMurray, J.J.V., et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38:8 (2014), 1110–1114, 10.1038/ijo.2013.203.
21. Carbone, S., Lavie, C.J., Arena, R., The obesity paradigm and lifetime risk of cardiovascular disease. JAMA Cardiol., 2018 Jul 11, 10.1001/jamacardio.2018.1834 [Epub ahead of print].
22. Parto, P., Lavie, C.J., Obesity and cardiovascular diseases. Curr Probl Cardiol 42:11 (2017), 376–394, 10.1016/j.cpcardiol.2017.04.004.
23. Parto, P., Lavie, C.J., Arena, R., Bond, S., Popovic, D., Ventura, H.O., Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox. Future Cardiol 12:6 (2016), 639–653, 10.2217/fca-2016-0029.
24. Van Tassell, B.W., Toldo, S., Mezzaroma, E., Abbate, A., Targeting interleukin-1 in heart disease. Circulation 128:17 (2013), 1910–1923, 10.1161/CIRCULATIONAHA.113.003199.
25. O'Brien, L.C., Mezzaroma, E., Van Tassell, B.W., et al. Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure. Mol Med 20 (2014), 221–229, 10.2119/molmed.2014.00034.
26. Carbone, S., Lee, P.J.H., Mauro, A.G., et al. Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse. Nutr Diabetes, 7(4), 2017, e258, 10.1038/nutd.2017.1.
27. Pascual, M., D A, Pascual, Soria, F., et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 89:10 (2003), 1152–1156, 10.1136/heart.89.10.1152.
28. Braunwald, E., Heart failure. JACC Heart Fail 1:1 (2013), 1–20, 10.1016/j.jchf.2012.10.002.
29. Lavie, C.J., Milani, R.V., Ventura, H.O., Adipose composition and heart failure prognosis: paradox or not?. J Am Coll Cardiol 70:22 (2017), 2750–2751, 10.1016/j.jacc.2017.10.017.
30. Wilson, P.W.F., D'Agostino, R.B., Sullivan, L., Parise, H., Kannel, W.B., Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:16 (2002), 1867–1872, 10.1001/archinte.162.16.1867.
31. Abdullah, A., Wolfe, R., Stoelwinder, J.U., et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 40:4 (2011), 985–996, 10.1093/ije/dyr018.
32. Kenchaiah, S., Evans, J.C., Levy, D., et al. Obesity and the risk of heart failure. N Engl J Med 347:5 (2002), 305–313, 10.1056/NEJMoa020245.
33. Pandey, A., LaMonte, M., Klein, L., et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol 69:9 (2017), 1129–1142, 10.1016/j.jacc.2016.11.081.
34. Pandey, A., Cornwell, W.K., Willis, B., et al. Body mass index and cardiorespiratory fitness in mid-life and risk of heart failure hospitalization in older age: findings from the cooper center longitudinal study. JACC Heart Fail 5:5 (2017), 367–374, 10.1016/j.jchf.2016.12.021.
35. Oreopoulos, A., Padwal, R., Kalantar-Zadeh, K., Fonarow, G.C., Norris, C.M., McAlister, F.A., Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:1 (2008), 13–22, 10.1016/j.ahj.2008.02.014.
36. Sharma, A., Lavie, C.J., Borer, J.S., et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115:10 (2015), 1428–1434, 10.1016/j.amjcard.2015.02.024.
37. Clark, A.L., Fonarow, G.C., Horwich, T.B., Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 17:5 (2011), 374–380, 10.1016/j.cardfail.2011.01.009.
38. Clark, A.L., Chyu, J., Horwich, T.B., The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 110:1 (2012), 77–82, 10.1016/j.amjcard.2012.02.050.
39. Shah, R., Gayat, E., Januzzi, J.L. Jr., et al. Body mass index and mortality in acutely decompensated heart failure across the world: A global obesity paradox. J Am Coll Cardiol 63:8 (2014), 778–785, 10.1016/j.jacc.2013.09.072.
40. Lavie, C.J., Ventura, H.O., The obesity paradox in heart failure: is it all about fitness, fat, or sex?. JACC Heart Fail 3:11 (2015), 927–930, 10.1016/j.jchf.2015.07.009.
41. Vest, A.R., Wu, Y., Hachamovitch, R., Young, J.B., Cho, L., The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 3:11 (2015), 917–926, 10.1016/j.jchf.2015.06.009.
42. Hirayama, A., Goto, T., Shimada, Y.J., Faridi, M.K., Camargo, C.A., Hasegawa, K., Association of obesity with severity of heart failure exacerbation: a population-based study. J Am Heart Assoc, 7(6), 2018, e008243, 10.1161/JAHA.117.008243.
43. Clark, A.L., Fonarow, G.C.H.T., Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 56:4 (2014), 409–414, 10.1016/j.pcad.2013.10.004.
44. Cicoira, M., Zanolla, L., Franceschini, L., et al. Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol 37:8 (2001), 2080–2085, 10.1016/S0735-1097%2801%2901306-7.
45. Carbone, S., Popovic, D., Lavie, C.J., Arena, R., Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fraction. Future Cardiol, 2017, 10.2217/fca-2017-0023 [Epub ahead of print].
46. Yusuf, S., Hawken, S., Ounpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet 364:9438 (2004), 937–952, 10.1016/S0140-6736(04)17018-9.
47. Romero-Corral, A., Montori, V.M., Somers, V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:9536 (2006), 666–678, 10.1016/S0140-6736(06)69251-9.
48. Wang, Z.J., Zhou, Y.J., Galper, B.Z., Gao, F., Yeh, R.W., Mauri, L., Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 101:20 (2015), 1631–1638, 10.1136/heartjnl-2014-307119.
49. Lavie, C.J., Oktay, A.A., Milani, R.V., The obesity paradox and obesity severity in elderly STEMI patients. Eur Heart J Qual Care Clin Outcomes 3:3 (2017), 166–167, 10.1093/ehjqcco/qcx018.
50. Lavie, C.J., Carbone, S., Agarwal, M.A., An obesity paradox with myocardial infarction in the elderly. Nutrition 46 (2018), 122–123, 10.1016/j.nut.2017.08.003.
51. Sharma, A., Vallakati, A., Einstein, A.J., et al. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 89:8 (2014), 1080–1100, 10.1016/j.mayocp.2014.04.020.
52. Pan, W., Hindler, K., Lee, V.-V., Vaughn, W.K., Collard, C.D., Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 104:3 (2006), 441–447, 10.1097/00000542-200603000-00010.
53. Gelber, R.P., Gaziano, J.M., Manson, J.E., Buring, J.E., Sesso, H.D., A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 20:4 (2007), 370–377, 10.1016/j.amjhyper.2006.10.011.
54. Uretsky, S., Messerli, F.H., Bangalore, S., et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120:10 (2007), 863–870, 10.1016/j.amjmed.2007.05.011.
55. Agarwal, M.A., Shah, M., Garg, L., Lavie, C.J., Relationship between obesity and survival in patients hospitalized for hypertensive emergency. Mayo Clin Proc 93:2 (2018), 263–265, 10.1016/j.mayocp.2017.07.015.
56. Agarwal, M., Agrawal, S., Garg, L., Lavie, C.J., Relation between obesity and survival in patients hospitalized for pulmonary arterial hypertension (from a Nationwide inpatient sample database 2003 to 2011). Am J Cardiol 120:3 (2017), 489–493, 10.1016/j.amjcard.2017.04.051.
57. Zafrir, B., Adir, Y., Shehadeh, W., Shteinberg, M., Salman, N., Amir, O., The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox.”. Respir Med 107:1 (2013), 139–146, 10.1016/j.rmed.2012.10.019.
58. Poms, A.D., Turner, M., Farber, H.W., Meltzer, L.A., McGoon, M.D., Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a reveal registry analysis. Chest 144:1 (2013), 169–176, 10.1378/chest.11-3241.
59. Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease. Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:21 (2009), 1925–1932, 10.1016/j.jacc.2008.12.068.
60. Lavie, C.J., Pandey, A., Lau, D.H., Alpert, M.A., Sanders, P., Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 70:16 (2017), 2022–2035, 10.1016/j.jacc.2017.09.002.
61. Wanahita, N., Messerli, F.H., Bangalore, S., Gami, A.S., Somers, V.K., Steinberg, J.S., Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155:2 (2008), 310–315, 10.1016/j.ahj.2007.10.004.
62. Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292:20 (2004), 2471–2477, 10.1001/jama.292.20.2471.
63. Wong, C.X., Sun, M.T., Odutayo, A., et al. Associations of Epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol, 9(12), 2016, e004378, 10.1161/CIRCEP.116.004378.
64. Pandey, A., Gersh, B.J., McGuire, D.K., et al. Association of body mass index with care and outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry. JACC Clin Electrophysiol 2:3 (2016), 355–363, 10.1016/j.jacep.2015.12.001.
65. Ortega, F.B., Lavie, C.J., Blair, S.N., Obesity and cardiovascular disease. Circ Res 118:11 (2016), 1752–1770, 10.1161/CIRCRESAHA.115.306883.
66. Lavie, C.J., De Schutter, A., Patel, D., Artham, S.M., Milani, R.V., Body composition and coronary heart disease mortality—an obesity or a lean paradox?. Mayo Clin Proc 86:9 (2011), 857–864, 10.4065/mcp.2011.0092.
67. Pocock, S.J., McMurray, J.J.V., Dobson, J., et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:21 (2008), 2641–2650, 10.1093/eurheartj/ehn420.
68. von Haehling, S., Morley, J.E., Anker, S.D., An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1:2 (2010), 129–133, 10.1007/s13539-010-0014-2.
69. Bekfani, T., Pellicori, P., Morris, D.A., et al. Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. Int J Cardiol 222 (2016), 41–46, 10.1016/j.ijcard.2016.07.135.
70. Kamiya, K., Masuda, T., Matsue, Y., et al. Complementary role of arm circumference to body mass index in risk stratification in heart failure. JACC Heart Fail 4:4 (2016), 265–273, 10.1016/j.jchf.2015.11.010.
71. Lavie, C.J., Forman, D.E., Arena, R., Bulking up skeletal muscle to improve heart failure prognosis. JACC Heart Fail 4:4 (2016), 274–276, 10.1016/j.jchf.2015.12.005.
72. Kaminsky, L.A., Arena, R., Beckie, T.M., et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the american heart association. Circulation 127:5 (2013), 652–662, 10.1161/CIR.0b013e31827ee100.
73. Oktay, A.A., Lavie, C.J., Kokkinos, P.F., Parto, P., Pandey, A., Ventura, H.O., The interaction of cardiorespiratory fitness with obesity and the obesity paradox in cardiovascular disease. Prog Cardiovasc Dis 60:1 (2017), 30–44, 10.1016/j.pcad.2017.05.005.
74. Ortega, F.B., Ruiz, J.R., Labayen, I., Lavie, C.J., Blair, S.N., The fat but fit paradox: what we know and don't know about it. Br J Sports Med 52:3 (2017), 151–153, 10.1136/bjsports-2016-097400.
75. Barry, V.W., Baruth, M., Beets, M.W., Durstine, J.L., Liu, J., Blair, S.N., Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Dis 56:4 (2014), 382–390, 10.1016/j.pcad.2013.09.002.
76. De Schutter, A., Kachur, S., Lavie, C.J., et al. Cardiac Rehabilitation Fitness Changes and Subsequent Survival. Eur Heart J Qual Care Clin Outcomes, April 2018, 10.1093/ehjqcco/qcy018 [Epub ahead of print].
77. Pedersen, B.K., Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports 17:3 (2007), 196–204, 10.1111/j.1600-0838.2006.00626.x.
78. McAuley, P.A., Artero, E.G., Sui, X., et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 87:5 (2012), 443–451, 10.1016/j.mayocp.2012.01.013.
79. McAuley, P.A., Beavers, K.M., Contribution of cardiorespiratory fitness to the obesity paradox. Prog Cardiovasc Dis 56:4 (2014), 434–440, 10.1016/j.pcad.2013.09.006.
80. McAuley, P.A., Keteyian, S.J., Brawner, C.A., et al. Exercise capacity and the obesity paradox in heart failure: the FIT (Henry Ford exercise testing) project. Mayo Clin Proc 93:6 (2018), 701–708, 10.1016/j.mayocp.2018.01.026.
81. Kodama, S., Saito, K., Tanaka, S., et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301:19 (2009), 2024–2035, 10.1001/jama.2009.681.
82. Moholdt, T., Lavie, C.J., Nauman, J., Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease. J Am Coll Cardiol 71:10 (2018), 1094–1101, 10.1016/j.jacc.2018.01.011.
83. Pathak, R.K., Elliott, A., Middeldorp, M.E., et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation the CARDIO-FIT study. J Am Coll Cardiol 66:9 (2015), 985–996, 10.1016/j.jacc.2015.06.488.
84. Lee, D., Sui, X., Artero, E.G., et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the aerobics center longitudinal study. Circulation 124:23 (2011), 2483–2490, 10.1161/CIRCULATIONAHA.111.038422.
85. Uretsky, S., Supariwala, A., Gurram, S., et al. The interaction of exercise ability and body mass index upon long-term outcomes among patients undergoing stress-rest perfusion single-photon emission computed tomography imaging. Am Heart J 166:1 (2013), 127–133, 10.1016/j.ahj.2013.03.027.
86. Pandey, A., Garg, S., Khunger, M., et al. Dose-response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation 132:19 (2015), 1786–1794, 10.1161/CIRCULATIONAHA.115.015853.
87. Berry, J.D., Pandey, A., Gao, A., et al. Physical fitness and risk for heart failure and coronary artery disease. Circ Heart Fail 6:4 (2013), 627–634, 10.1161/CIRCHEARTFAILURE.112.000054.
88. Pandey, A., Berry, J.D., Physical activity in heart failure with preserved ejection fraction: moving toward a newer treatment paradigm. Circulation 136:11 (2017), 993–995, 10.1161/CIRCULATIONAHA.117.029935.
89. Omar, W., Pandey, A., Haykowsky, M.J., Berry, J.D., Lavie, C.J., The evolving role of cardiorespiratory fitness and exercise in prevention and management of heart failure. Curr Heart Fail Rep 15:2 (2018), 75–80, 10.1007/s11897-018-0382-z.
90. Lavie, C.J., Cahalin, L.P., Chase, P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88:3 (2013), 251–258, 10.1016/j.mayocp.2012.11.020.
91. Gupta, S., Rohatgi, A., Ayers, C.R., et al. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation 123:13 (2011), 1377–1383, 10.1161/CIRCULATIONAHA.110.003236.
92. Fenger-Grøn, M., Overvad, K., Tjønneland, A., Frost, L., Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. J Am Coll Cardiol 69:20 (2017), 2488–2497, 10.1016/j.jacc.2017.03.558.
93. Kramer, C.K., Zinman, B., Retnakaran, R., Are metabolically healthy overweight and obesity benign conditions?. Ann Intern Med 159:11 (2013), 758–769, 10.7326/0003-4819-159-11-201312030-00008.
94. Mørkedal, B., Vatten, L.J., Romundstad, P.R., Laugsand, L.E., Janszky, I., Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag health study), Norway. J Am Coll Cardiol 63:11 (2014), 1071–1078, 10.1016/j.jacc.2013.11.035.
95. Mongraw-Chaffin, M., Foster, M.C., Anderson, C.A., et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 71:17 (2018), 1857–1865, 10.1016/j.jacc.2018.02.055.
96. Caleyachetty, R., Thomas, G.N., Toulis, K.A., et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol 70:12 (2017), 1429–1437, 10.1016/j.jacc.2017.07.763.
97. Kennedy, A.B., Lavie, C.J., Blair, S.N., Fitness or fatness: which is more important?. JAMA 319:3 (2018), 231–232, 10.1001/jama.2017.21649.
98. Lavie, C.J., Ortega, F.B., Kokkinos, P., Impact of physical activity and fitness in metabolically healthy obesity. J Am Coll Cardiol 71:7 (2018), 812–813, 10.1016/j.jacc.2017.10.106.
99. American Diabetes Association, 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care 41:Suppl 1 (2018), S13–S27, 10.2337/dc18-S002.
100. American Diabetes Association AD, 5. Prevention or delay of type 2 diabetes:standards of medical care in diabetes-2018. Diabetes Care 41:Suppl 1 (2018), S51–S54, 10.2337/dc18-S005.
101. Alpert, M.A., Terry, B.E., Mulekar, M., et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80:6 (1997), 736–740, 10.1016/S0002-9149(97)00505-5.
102. Lavie, C.J., Mehra, M.R., Ventura, H.O., Body composition and advanced heart failure therapy: weighing the options and outcomes. JACC Heart Fail 4:10 (2016), 769–771, 10.1016/j.jchf.2016.07.007.
103. Mehra, M.R., Canter, C.E., Hannan, M.M., et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 35:1 (2016), 1–23, 10.1016/j.healun.2015.10.023.
104. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 128:16 (2013), e240–e327, 10.1161/CIR.0b013e31829e8776.
105. Mcmurray, J.J.V., Adamopoulos, S., Anker, S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 14:8 (2012), 803–869, 10.1093/eurjhf/hfs105.
106. Carbone, S., Canada, J.M., Buckley, L.F., et al. Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68:22 (2016), 2487–2488, 10.1016/j.jacc.2016.08.072.
107. Kitzman, D.W., Brubaker, P., Morgan, T., et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315:1 (2016), 36–46, 10.1001/jama.2015.17346.
108. Pathak, R.K., Middeldorp, M.E., Meredith, M., et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 65:20 (2015), 2159–2169, 10.1016/j.jacc.2015.03.002.
109. Jahangir, E., De Schutter, A., Lavie, C.J., Low weight and overweightness in older adults: risk and clinical management. Prog Cardiovasc Dis 57:2 (2014), 127–133, 10.1016/j.pcad.2014.01.001.
110. De Schutter, A., Lavie, C.J., Milani, R.V., The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox. Prog Cardiovasc Dis 56:4 (2014), 401–408, 10.1016/j.pcad.2013.08.003.
111. Mozaffarian, D., Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 87:6 (2008), 1991S–1996S, 10.1093/ajcn/87.6.1991S.